Overall clinical success rates at TOC were 85.3 % ( 431 of 505 patients ) in the moxifloxacin and 88.4 % ( 459 of 519 patients ) in the comparator treatment groups ( PP population , point estimate for the difference in success rates : -3.0 % ; 95 % CI -7.06 % , 1.05 % ) , respectively .